Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -38.37%10.53K | 86.19%10.53K | -12.53%45.49K | -12.53%11.37K | -12.53%11.37K | 48.20%17.09K | -60.91%5.66K | -10.15%52.01K | -10.15%13K | -10.15%13K |
| Gross profit | 38.37%-10.53K | -86.19%-10.53K | 12.53%-45.49K | 12.53%-11.37K | 12.53%-11.37K | -48.20%-17.09K | 60.91%-5.66K | 10.15%-52.01K | 10.15%-13K | 10.15%-13K |
| Operating expense | 106.38%442.21K | -22.72%213.95K | 6.96%1.03M | 42.39%394.8K | -42.21%188.19K | -52.64%214.27K | 38.12%276.84K | 18.96%964.98K | 30.92%277.27K | 77.07%325.65K |
| Selling and administrative expenses | 88.56%237.52K | -37.95%96.95K | 13.43%542.33K | 51.81%262.89K | -27.51%69.18K | 47.73%125.96K | 24.99%156.25K | -0.18%478.13K | 28.61%173.17K | -6.56%95.44K |
| -Selling and marketing expense | 699.03%52.63K | -50.48%7.69K | -67.37%32.4K | -73.61%6.28K | -70.13%3.75K | 39.47%6.59K | -73.36%15.52K | -33.09%99.3K | 58.34%23.79K | -34.68%12.56K |
| -General and administrative expense | 54.88%184.89K | -36.57%89.27K | 34.61%509.93K | 71.78%256.61K | -21.06%65.43K | 48.21%119.37K | 110.86%140.73K | 14.60%378.83K | 24.87%149.38K | -0.04%82.88K |
| Other operating expenses | 131.80%204.69K | -2.98%117K | 0.61%489.81K | 26.71%131.91K | -48.30%119.01K | -75.95%88.31K | 59.87%120.59K | 46.57%486.85K | 34.96%104.1K | 181.52%230.21K |
| Operating profit | -95.69%-452.74K | 20.54%-224.48K | -5.96%-1.08M | -39.93%-406.17K | 41.07%-199.56K | 50.13%-231.36K | -31.45%-282.49K | -17.03%-1.02M | -28.30%-290.27K | -70.71%-338.65K |
| Net non-operating interest income (expenses) | 41.83%-1.59K | -79.20%-5.28K | -19.51%-15.73K | -141.17%-7.4K | 17.41%-2.65K | 19.06%-2.74K | 15.97%-2.95K | -728.70%-13.17K | -205.47%-3.07K | 15.34%-3.21K |
| Non-operating interest income | --668 | ---- | ---- | ---- | ---- | --0 | ---- | --0 | ---- | ---- |
| Non-operating interest expense | -17.40%2.26K | 79.20%5.28K | 19.51%15.73K | 141.17%7.4K | -17.41%2.65K | -19.06%2.74K | -15.97%2.95K | -15.64%13.17K | -21.27%3.07K | -15.34%3.21K |
| Other net income (expenses) | 2,770.20%481.07K | 10,249.13%136.3K | 56.66%583.55K | 102.41%557.24K | -74.77%10.31K | -54.26%16.76K | -93.53%1.32K | 72.03%372.49K | 81.82%275.31K | 13.13%40.89K |
| Gain on sale of security | 214,865.18%481.07K | 14,447.16%136.3K | 353.35%557.41K | 348.00%548.27K | 976.62%10.31K | -179.72%-224 | -419.13%-950 | -348.79%-220.02K | -435.36%-221.08K | -97.35%958 |
| Other non-operating income (expenses) | ---- | ---- | -95.59%26.14K | -98.19%8.97K | ---- | -53.29%16.99K | -88.97%2.27K | 362.58%592.51K | 480.59%496.38K | --39.93K |
| Income before tax | 112.30%26.74K | 67.10%-93.47K | 22.48%-509.82K | 896.95%143.67K | 36.24%-191.9K | 49.53%-217.33K | -43.46%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 112.30%26.74K | 67.10%-93.47K | 22.48%-509.82K | 896.95%143.67K | 36.24%-191.9K | 49.53%-217.33K | -43.46%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Net income continuous operations | 112.30%26.74K | 67.10%-93.47K | 22.48%-509.82K | 896.95%143.67K | 36.24%-191.9K | 49.53%-217.33K | -43.46%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 110.80%26.74K | 67.10%-93.47K | 22.48%-509.82K | 1,485.36%249.75K | 24.30%-227.85K | -76.05%-247.6K | -43.48%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 110.80%26.74K | 67.10%-93.47K | 22.48%-509.82K | 1,485.36%249.75K | 24.30%-227.85K | -76.05%-247.6K | -43.48%-284.12K | -1.11%-657.66K | 74.93%-18.03K | -81.27%-300.97K |
| Diluted earnings per share | 0 | 60.00%-0.002 | 25.00%-0.009 | 0.005 | 20.00%-0.004 | -33.33%-0.004 | -25.00%-0.005 | 0.00%-0.012 | 0 | -25.00%-0.005 |
| Basic earnings per share | 0 | 60.00%-0.002 | 25.00%-0.009 | 0.005 | 20.00%-0.004 | -33.33%-0.004 | -25.00%-0.005 | 0.00%-0.012 | 0 | -25.00%-0.005 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.